Heppinn Biosciences was established to support clients identify and diligence potential investments, start biotech companies, and develop therapeutics. Ongoing work is with Venture Capital groups, early-stage companies, university tech transfer offices, and disease foundations. Key activities include scientific diligence, landscape and/or gap analysis, technology development, fundraising and KOL engagement, and opinion memos.